Robert S. Copeland-Halperin

Robert S. Copeland-Halperin

Cardiology

270-05 76th Avenue, Oncology Building
3rd Floor
New Hyde Park, NY 11040

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Presentation, Treatment, and Outcomes of Non-bacterial Thrombotic Endocarditis in Pancreatic Cancer: A Systematic Review.

Presentation, Treatment, and Outcomes of Non-bacterial Thrombotic Endocarditis in Pancreatic Cancer: A Systematic Review.

Journal: Cureus

Published: February 24, 2026

Arrhythmias and cardiac devices management in oncology patients.

Arrhythmias and cardiac devices management in oncology patients.

Journal: Heart rhythm

Published: December 04, 2025

Considerations for the practical management of cardiovascular risk with Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia.

Considerations for the practical management of cardiovascular risk with Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia.

Journal: The oncologist

Published: March 25, 2025

Non-bacterial Thrombotic Endocarditis in Lung Cancer: A Systematic Review.

Non-bacterial Thrombotic Endocarditis in Lung Cancer: A Systematic Review.

Journal: Current cardiology reviews

Published: August 09, 2024

New-Onset Graves' Disease Presenting As Thyro-Pericarditis.

New-Onset Graves' Disease Presenting As Thyro-Pericarditis.

Journal: Cureus

Published: July 22, 2024

Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology.

Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology.

Journal: Cardiorenal medicine

Published: March 19, 2024

Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Nomogram for Predicting Risk of Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.

Journal: Journal of the American Heart Association

Published: September 26, 2023

Racial and Socioeconomic Disparities in Cardiotoxicity Among Women With HER2-Positive Breast Cancer.

Racial and Socioeconomic Disparities in Cardiotoxicity Among Women With HER2-Positive Breast Cancer.

Journal: The American journal of cardiology

Published: December 11, 2020

Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer.

Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer.

Journal: JAMA oncology

Published: October 15, 2020

Cardiotoxicity of HER2-targeted therapies.

Cardiotoxicity of HER2-targeted therapies.

Journal: Current opinion in cardiology

Published: May 15, 2019

Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry.

Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry.

Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

Published: May 31, 2017

Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences.

Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences.

Journal: Journal of the American College of Cardiology

Published: February 27, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026